Daily BriefsEvent-Driven

Event-Driven: Toyo Construction, Singapore Press Holdings, Kuaishou Technology, Mapletree North Asia Commercial Trust, Monex Group Inc, True Corp Pcl, Bluerock Residential Growth and more

In today’s briefing:

  • Infroneer (5076 JP) Tender Offer for Toyo Construction (1890 JP) Could Get Funky
  • SPH Shareholders Agree to SPH EGM & DIS – Deal Done So Now It’s Arb+Option
  • Potential MSCI Upweights in May: Kuaishou, JD Health, Akeso
  • MCT and MNACT’s New Cash-Only Scheme Option Gets Quarz Onside
  • Monex – Coincheck SPAC Unlocks Value
  • True/​DTAC Merger: Shareholder Meetings, IFA Opinion, & Expected Timetable
  • SpinTalk: Why The Blackstone/Bluerock Merger Deal Remains Compelling…And It’s Not The Merger

Infroneer (5076 JP) Tender Offer for Toyo Construction (1890 JP) Could Get Funky

By Travis Lundy

  • INFRONEER Holdings (5076 JP) is the new name of the holding company which was comprised of Maeda Corporation, Maeda Road Construction, and Maeda Seisakusho.
  • Infroneer owns a 20% stake in smaller construction company Toyo Construction (1890 JP) through subsidiary Maeda Construction. It has launched a Tender Offer for the rest at a 28.5% premium.
  • This could get complicated. If you own, I would not sell at terms.

SPH Shareholders Agree to SPH EGM & DIS – Deal Done So Now It’s Arb+Option

By Travis Lundy

  • Topday, Singapore Press Holdings (SPH SP) shareholders met in an EGM and a Scheme Meeting to approve the takeover of SPH and distribution of SPH REIT (SPHREIT SP) units.
  • Shareholders passed resolutions at both meetings, meaning the Cuscaden Peak Pte acquisition is approved. 
  • This means we move to next steps, which is choosing the Consideration, and possible MGO Chain Offer on SPH REIT (SPHREIT SP)

Potential MSCI Upweights in May: Kuaishou, JD Health, Akeso

By Brian Freitas

  • We see a potential increase in the FIF for Kuaishou Technology (1024 HK), JD Health (6618 HK) and Akeso Biopharma Inc (9926 HK) at the MSCI May SAIR.
  • The increase in FIF will require passive funds to buy 79.45m shares of Kuaishou (1024 HK), 57.35m shares of JD Health (6618 HK) and 15.32m shares of Akeso (9926 HK).
  • Short interest has started to inch higher on Kuaishou, while short interest is rising sharply on JD Health and Akeso.

MCT and MNACT’s New Cash-Only Scheme Option Gets Quarz Onside

By Arun George

  • Mapletree Commercial Trust (MCT SP) has introduced a new cash-only consideration of S$1.1949 per MNACT unit. The scheme meeting is at the end-May with an effective date of end-August. 
  • Mapletree North Asia Commercial Trust (MAGIC SP)/MNACT will continue to be able to pay permitted distributions – consensus 2HFY21/22 DPU of 3.57 cents to be paid in June.
  • Quarz Capital now supports the merger. Including potential permitted 2H MNACT DPU and at last close, the gross spread to the cash-only consideration is 0.9%. 

Monex – Coincheck SPAC Unlocks Value

By Mio Kato

  • Coincheck and Thunder Bridge Capital Partners IV announced today that an SPAC deal would occur to list Coincheck on the NASDAQ. 
  • With a pre-money valuation of $1.25bn the deal values Coincheck noticeably more modestly than Monex’s prior SOTP presentation. 
  • Nevertheless, in combination with the announced TradeStation SPAC it starts to make the extent of Monex’s holdco discount apparent.

True/​DTAC Merger: Shareholder Meetings, IFA Opinion, & Expected Timetable

By David Blennerhassett

  • The Information Memorandum is out regarding the True Corp Pcl (TRUE TB) / Total Access Communication (DTAC TB) merger.
  • The shareholder meetings for both companies will be held on the 4 April, with a tentative listing date of the NewCo late September.
  • The IFAs for both companies are of the opinion that shareholders should approve the Amalgamation. 

SpinTalk: Why The Blackstone/Bluerock Merger Deal Remains Compelling…And It’s Not The Merger

By Robert Sassoon

  • Notwithstanding the 70% plus  Bluerock Residential Growth (BRG US) share price rise since deal announcement, there’s more juice to be squeezed out of this trade for arbs and fundamental investors
  • The attractive spin-off element of the transaction is all but ignored in the prevailing Bluerock Residential Growth (BRG US) share price
  • Potential for at least 140% gain for fundamental investors and additional 40% plus IRR for arbs

Before it’s here, it’s on Smartkarma